Ryuvidine
CAS No. 265312-55-8
Ryuvidine ( SPS8I-2 )
Catalog No. M13813 CAS No. 265312-55-8
Ryuvidine is a potent, selective CDK4 inhibitor with IC50 of 6.0 uM, displays >30-fold selectivity over CDK2 (IC50>100 uM).
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
5MG | 873 | Get Quote |
|
50MG | 1782 | Get Quote |
|
100MG | 2250 | Get Quote |
|
200MG | Get Quote | Get Quote |
|
500MG | Get Quote | Get Quote |
|
1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameRyuvidine
-
NoteResearch use only, not for human use.
-
Brief DescriptionRyuvidine is a potent, selective CDK4 inhibitor with IC50 of 6.0 uM, displays >30-fold selectivity over CDK2 (IC50>100 uM).
-
DescriptionRyuvidine is a potent, selective CDK4 inhibitor with IC50 of 6.0 uM, displays >30-fold selectivity over CDK2 (IC50>100 uM); shows potent cytototoxic activity against HL-60, A549, Col 1, HepG2 cancer cell lines with IC50 of 0.3-1.2 ug/mL; also inhibits SETD8 with IC50 of 0.5 uM, efficiently and selectively suppresses cellular H4K20me1 at doses lower than 5 uM.
-
SynonymsSPS8I-2
-
PathwayAngiogenesis
-
TargetCDK
-
RecptorCDK
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number265312-55-8
-
Formula Weight284.30
-
Molecular FormulaC15H12N2O2S
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCC1=NC2=C(C(C=C(NC3=CC=C(C)C=C3)C2=O)=O)S1
-
Chemical Name2-methyl-5-[(4-methylphenyl)amino]-4,7-benzothiazoledione
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Blum G, et al. ACS Chem Biol. 2014 Nov 21;9(11):2471-8.
2. Ryu CK, et al. Bioorg Med Chem Lett. 2000 Mar 6;10(5):461-4.
3. Lang E, et al. Cell Physiol Biochem. 2015;37(3):1178-86.
2. Ryu CK, et al. Bioorg Med Chem Lett. 2000 Mar 6;10(5):461-4.
3. Lang E, et al. Cell Physiol Biochem. 2015;37(3):1178-86.
molnova catalog
related products
-
BMS-265246
BMS-265246 is a potent and selective CDK1/2 inhibitor with IC50 of 6 nM/9 nM in a cell-free assay.
-
HSD992
HSD992 is a potent, selective CDK2/3 inhibitor with moderate CDK9 inhibition with IC50 of 18 nM, 57 nM and 49 nM for CDK3/cyclin E, CDK2/cyclin A1 and CDK2/cyclin E, respecively.
-
Ro-3306
Ro-3306 is a potent, selective, ATP-competitive CDK1 inhibitor with Ki of 35 nM against CDK1/cyclin B1, 10-fold selectivity relative to CDK2/cyclin E and >50-fold relative to CDK4/cyclin D.